MAREX GROUP PLC (MRX) Fundamental Analysis & Valuation

NASDAQ:MRX • GB00BMT7GT62

Current stock price

52.78 USD
-0.34 (-0.64%)
At close:
52.78 USD
0 (0%)
After Hours:

This MRX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. MRX Profitability Analysis

1.1 Basic Checks

  • In the past year MRX was profitable.
  • In the past year MRX had a positive cash flow from operations.
  • In the past 5 years MRX has always been profitable.
  • MRX had a positive operating cash flow in each of the past 5 years.
MRX Yearly Net Income VS EBIT VS OCF VS FCFMRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

1.2 Ratios

  • MRX has a worse Return On Assets (0.85%) than 64.44% of its industry peers.
  • The Return On Equity of MRX (23.29%) is better than 87.87% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 0.95%, MRX is doing worse than 71.55% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for MRX is significantly below the industry average of 7.30%.
Industry RankSector Rank
ROA 0.85%
ROE 23.29%
ROIC 0.95%
ROA(3y)0.81%
ROA(5y)0.81%
ROE(3y)20.25%
ROE(5y)17.22%
ROIC(3y)1.87%
ROIC(5y)N/A
MRX Yearly ROA, ROE, ROICMRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 0 5 10 15 20

1.3 Margins

  • The Profit Margin of MRX (8.58%) is comparable to the rest of the industry.
  • In the last couple of years the Profit Margin of MRX has declined.
  • MRX has a Operating Margin of 5.89%. This is in the lower half of the industry: MRX underperforms 74.06% of its industry peers.
  • Looking at the Gross Margin, with a value of 53.20%, MRX is in the better half of the industry, outperforming 60.25% of the companies in the same industry.
  • MRX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.89%
PM (TTM) 8.58%
GM 53.2%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-4.59%
PM growth 5YN/A
GM growth 3Y3.52%
GM growth 5YN/A
MRX Yearly Profit, Operating, Gross MarginsMRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025 0 20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. MRX Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, MRX has more shares outstanding
  • The debt/assets ratio for MRX has been reduced compared to a year ago.
MRX Yearly Shares OutstandingMRX Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 20M 40M 60M
MRX Yearly Total Debt VS Total AssetsMRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • MRX has an Altman-Z score of 0.32. This is a bad value and indicates that MRX is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 0.32, MRX is not doing good in the industry: 71.97% of the companies in the same industry are doing better.
  • The Debt to FCF ratio of MRX is 27.61, which is on the high side as it means it would take MRX, 27.61 years of fcf income to pay off all of its debts.
  • MRX's Debt to FCF ratio of 27.61 is in line compared to the rest of the industry. MRX outperforms 51.88% of its industry peers.
  • MRX has a Debt/Equity ratio of 11.45. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 11.45, MRX is doing worse than 89.96% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 11.45
Debt/FCF 27.61
Altman-Z 0.32
ROIC/WACCN/A
WACCN/A
MRX Yearly LT Debt VS Equity VS FCFMRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 1.09 indicates that MRX should not have too much problems paying its short term obligations.
  • MRX has a Current ratio (1.09) which is comparable to the rest of the industry.
  • A Quick Ratio of 1.07 indicates that MRX should not have too much problems paying its short term obligations.
  • MRX has a Quick ratio (1.07) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.07
MRX Yearly Current Assets VS Current LiabilitesMRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. MRX Growth Analysis

3.1 Past

  • MRX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 42.32%, which is quite impressive.
  • Measured over the past years, MRX shows a very strong growth in Earnings Per Share. The EPS has been growing by 44.09% on average per year.
  • The Revenue has grown by 25.39% in the past year. This is a very strong growth!
  • The Revenue has been growing by 54.67% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)42.32%
EPS 3Y44.09%
EPS 5YN/A
EPS Q2Q%48.68%
Revenue 1Y (TTM)25.39%
Revenue growth 3Y54.67%
Revenue growth 5YN/A
Sales Q2Q%37.66%

3.2 Future

  • MRX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.51% yearly.
  • The Revenue is expected to grow by 14.06% on average over the next years. This is quite good.
EPS Next Y18.42%
EPS Next 2Y14.51%
EPS Next 3Y14.51%
EPS Next 5YN/A
Revenue Next Year23.41%
Revenue Next 2Y15.43%
Revenue Next 3Y14.06%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
MRX Yearly Revenue VS EstimatesMRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
MRX Yearly EPS VS EstimatesMRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. MRX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 13.13, which indicates a correct valuation of MRX.
  • The rest of the industry has a similar Price/Earnings ratio as MRX.
  • When comparing the Price/Earnings ratio of MRX to the average of the S&P500 Index (26.91), we can say MRX is valued rather cheaply.
  • The Price/Forward Earnings ratio is 11.09, which indicates a very decent valuation of MRX.
  • MRX's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. MRX is cheaper than 63.18% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 21.99. MRX is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 13.13
Fwd PE 11.09
MRX Price Earnings VS Forward Price EarningsMRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, MRX is valued cheaper than 84.10% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.96
EV/EBITDA -52.99
MRX Per share dataMRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • MRX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as MRX's earnings are expected to grow with 14.51% in the coming years.
PEG (NY)0.71
PEG (5Y)N/A
EPS Next 2Y14.51%
EPS Next 3Y14.51%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

2

5. MRX Dividend Analysis

5.1 Amount

  • MRX has a Yearly Dividend Yield of 1.15%. Purely for dividend investing, there may be better candidates out there.
  • MRX's Dividend Yield is slightly below the industry average, which is at 6.53.
  • Compared to the average S&P500 Dividend Yield of 1.82, MRX is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.15%

5.2 History

  • MRX has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
MRX Yearly Dividends per shareMRX Yearly Dividends per shareYearly Dividends per share 2024 2025 2026 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

  • MRX pays out 18.85% of its income as dividend. This is a sustainable payout ratio.
DP18.85%
EPS Next 2Y14.51%
EPS Next 3Y14.51%
MRX Yearly Income VS Free CF VS DividendMRX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
MRX Dividend Payout.MRX Dividend Payout, showing the Payout Ratio.MRX Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

MRX Fundamentals: All Metrics, Ratios and Statistics

MAREX GROUP PLC

NASDAQ:MRX (4/28/2026, 8:00:01 PM)

After market: 52.78 0 (0%)

52.78

-0.34 (-0.64%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Industry StrengthN/A
Industry GrowthN/A
Earnings (Last)03-03
Earnings (Next)05-13
Inst Owners74.27%
Inst Owner Change0%
Ins Owners5.57%
Ins Owner Change-0.89%
Market Cap3.86B
Revenue(TTM)3.43B
Net Income(TTM)294.40M
Analysts80
Price Target55.37 (4.91%)
Short Float %5.18%
Short Ratio2.58
Dividend
Industry RankSector Rank
Dividend Yield 1.15%
Yearly Dividend0.72
Dividend Growth(5Y)N/A
DP18.85%
Div Incr Years1
Div Non Decr Years1
Ex-Date03-16
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.03%
Min EPS beat(2)2.66%
Max EPS beat(2)9.4%
EPS beat(4)3
Avg EPS beat(4)5.43%
Min EPS beat(4)-0.13%
Max EPS beat(4)9.79%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)5.94%
Min Revenue beat(2)0.61%
Max Revenue beat(2)11.26%
Revenue beat(4)4
Avg Revenue beat(4)4.69%
Min Revenue beat(4)0.61%
Max Revenue beat(4)11.26%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.85%
PT rev (3m)11.76%
EPS NQ rev (1m)24.98%
EPS NQ rev (3m)33.37%
EPS NY rev (1m)10.91%
EPS NY rev (3m)10.7%
Revenue NQ rev (1m)21.2%
Revenue NQ rev (3m)33.09%
Revenue NY rev (1m)4.4%
Revenue NY rev (3m)11.27%
Valuation
Industry RankSector Rank
PE 13.13
Fwd PE 11.09
P/S 1.12
P/FCF 5.96
P/OCF 5.78
P/B 3.05
P/tB 4.16
EV/EBITDA -52.99
EPS(TTM)4.02
EY7.62%
EPS(NY)4.76
Fwd EY9.02%
FCF(TTM)8.86
FCFY16.79%
OCF(TTM)9.13
OCFY17.3%
SpS46.94
BVpS17.29
TBVpS12.7
PEG (NY)0.71
PEG (5Y)N/A
Graham Number39.5471 (-25.07%)
Profitability
Industry RankSector Rank
ROA 0.85%
ROE 23.29%
ROCE 5.44%
ROIC 0.95%
ROICexc 4.71%
ROICexgc 5.27%
OM 5.89%
PM (TTM) 8.58%
GM 53.2%
FCFM 18.88%
ROA(3y)0.81%
ROA(5y)0.81%
ROE(3y)20.25%
ROE(5y)17.22%
ROIC(3y)1.87%
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)11.79%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-4.59%
PM growth 5YN/A
GM growth 3Y3.52%
GM growth 5YN/A
F-Score6
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 11.45
Debt/FCF 27.61
Debt/EBITDA 60.77
Cap/Depr 54.85%
Cap/Sales 0.58%
Interest Coverage 250
Cash Conversion 280.23%
Profit Quality 220.01%
Current Ratio 1.09
Quick Ratio 1.07
Altman-Z 0.32
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)59.73%
Cap/Depr(5y)63.64%
Cap/Sales(3y)0.58%
Cap/Sales(5y)0.72%
Profit Quality(3y)447.82%
Profit Quality(5y)479.97%
High Growth Momentum
Growth
EPS 1Y (TTM)42.32%
EPS 3Y44.09%
EPS 5YN/A
EPS Q2Q%48.68%
EPS Next Y18.42%
EPS Next 2Y14.51%
EPS Next 3Y14.51%
EPS Next 5YN/A
Revenue 1Y (TTM)25.39%
Revenue growth 3Y54.67%
Revenue growth 5YN/A
Sales Q2Q%37.66%
Revenue Next Year23.41%
Revenue Next 2Y15.43%
Revenue Next 3Y14.06%
Revenue Next 5YN/A
EBIT growth 1Y38.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year18.46%
EBIT Next 3Y17.14%
EBIT Next 5YN/A
FCF growth 1Y-43.36%
FCF growth 3Y44.16%
FCF growth 5YN/A
OCF growth 1Y-42.63%
OCF growth 3Y43.56%
OCF growth 5YN/A

MAREX GROUP PLC / MRX Fundamental Analysis FAQ

What is the fundamental rating for MRX stock?

ChartMill assigns a fundamental rating of 4 / 10 to MRX.


What is the valuation status for MRX stock?

ChartMill assigns a valuation rating of 6 / 10 to MAREX GROUP PLC (MRX). This can be considered as Fairly Valued.


What is the profitability of MRX stock?

MAREX GROUP PLC (MRX) has a profitability rating of 4 / 10.


What are the PE and PB ratios of MAREX GROUP PLC (MRX) stock?

The Price/Earnings (PE) ratio for MAREX GROUP PLC (MRX) is 13.13 and the Price/Book (PB) ratio is 3.05.


Can you provide the financial health for MRX stock?

The financial health rating of MAREX GROUP PLC (MRX) is 2 / 10.